Doctors’ soaring use of AI scribes prompts Australian government warning over privacy
Guardian AU
•Sat, 04 Jul 2026 20:00:07 GMT
📰 What Happened
The Australian federal health department has issued a warning about AI scribe tools being used by doctors to record, transcribe and summarise patient consultations. These AI systems have seen explosive growth, with RACGP polling showing usage among Australian GPs nearly doubling from 22% in August 2024 to 40% by November 2025 — meaning two in five GPs now use them. The health department says these tools 'have little oversight' and the Therapeutic Goods Administration is now considering whether safeguards are needed. Companies behind the technology claim the tools have been used hundreds of millions of times globally in the past 18 months.
🔍 The Backstory
AI scribes emerged as a solution to doctor burnout caused by the administrative burden of medical documentation. The technology promised to let doctors focus on patients rather than note-taking. However, concerns rapidly grew about how patient data is stored, who has access to it, whether recordings are kept, and whether the AI accurately captures sensitive medical information. Australia's health privacy framework was not designed with real-time AI transcription in mind, creating a regulatory gap. The RACGP itself has raised questions about whether the convenience trade-off compromises patient care and confidentiality.
🎯 Why It Matters
The rapid, unregulated adoption of AI scribes in healthcare poses significant privacy risks for millions of Australian patients, and the government's belated scrutiny highlights the gap between technological adoption and regulatory frameworks in digital health.
The Australian federal health department has issued a warning about AI scribe tools being used by doctors to record, transcribe and summarise patient consultations. These AI systems have seen explosive growth, with RACGP polling showing usage among Australian GPs nearly doubling from 22% in August 2024 to 40% by November 2025 — meaning two in five GPs now use them. The health department says these tools 'have little oversight' and the Therapeutic Goods Administration is now considering whether safeguards are needed. Companies behind the technology claim the tools have been used hundreds of millions of times globally in the past 18 months.
AI scribes emerged as a solution to doctor burnout caused by the administrative burden of medical documentation. The technology promised to let doctors focus on patients rather than note-taking. However, concerns rapidly grew about how patient data is stored, who has access to it, whether recordings are kept, and whether the AI accurately captures sensitive medical information. Australia's health privacy framework was not designed with real-time AI transcription in mind, creating a regulatory gap. The RACGP itself has raised questions about whether the convenience trade-off compromises patient care and confidentiality.
The rapid, unregulated adoption of AI scribes in healthcare poses significant privacy risks for millions of Australian patients, and the government's belated scrutiny highlights the gap between technological adoption and regulatory frameworks in digital health.